MedTrace Logo

"Effect of Artificial Intelligence-Driven Mobile Application on Nurses' Knowledge and Attitudes Toward Atraumatic Care for Hospitalized Children"

NCT07446920 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 97

Last updated 2026-03-03

No results posted yet for this study

Summary

This randomized controlled trial aims to evaluate the effect of an artificial intelligence-driven mobile application on nurses' knowledge and attitudes toward atraumatic care for hospitalized children. Participants, who are pediatric nurses, will be randomly assigned to either the intervention group, using the mobile application, or the control group receiving standard education. The primary outcomes are improvements in nurses' knowledge and attitudes, measured after the intervention. The study seeks to determine whether the mobile application enhances nurses' competence in providing atraumatic care compared to usual training methods.

Conditions

  • Pediatric Nursing Education

Interventions

BEHAVIORAL

Atraumatic Care Training Program

The intervention consisted of an AI-driven mobile application designed to enhance nurses' knowledge and attitudes toward atraumatic care for hospitalized children. The application included educational modules covering principles, benefits, and purposes of atraumatic care. Each module provided AI-generated content and an interactive chat feature, requiring participants to ask at least three questions before unlocking a module-specific quiz. Participants completed all modules over one week, followed by a final assessment of 25 AI-generated questions covering all modules

BEHAVIORAL

No Intervention / Standard Care

Nurses in this group will continue their routine practice without receiving any additional training, mobile application, or educational program. Participants will provide pediatric care according to standard hospital protocols. This group serves as a comparison to evaluate the effect of the AI-driven mobile application on the experimental group.

Sponsors & Collaborators

  • University of Baghdad

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-29
Primary Completion
2026-02-02
Completion
2026-02-02

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07446920 on ClinicalTrials.gov